References | Journal | Year | |
Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis. Nault R, Fader KA, Ammendolia DA, Dornbos P, Potter D, Sharratt B, Kumagai K, Harkema JR, Lunt SY, Matthews J, Zacharewski T. | Toxicol Sci. | 2016 | View |
NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI). Ozkok A, Ravichandran K, Wang Q, Ljubanovic D, Edelstein CL. | Toxicol Lett. | 2016 | View |
An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease. Ravichandran K, Zafar I, Ozkok A, Edelstein CL. | Nephrol Dial Transplant. | 2015 | View |
Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2. Ravichandran K, Ozkok A, Wang Q, Mullick AE, Edelstein CL. | Am J Physiol Renal Physiol. | 2015 | View |
Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice. Joshi N, Kopec AK, O'Brien KM, Towery KL, Cline-Fedewa H, Williams KJ, Copple BL, Flick MJ, Luyendyk JP. | J Thromb Haemost. | 2015 | View |
Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats. Zhang Q, Davis KJ, Hoffmann D, Vaidya VS, Brown RP, Goering PL. | Biomark Med. | 2014 | View |
A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Sun CC, Vaja V, Chen S, Theurl I, Stepanek A, Brown DE, Cappellini MD, Weiss G, Hong CC, Lin HY, Babitt JL. | Nephrol Dial Transplant | 2013 | View |
An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male rats. Fuchs TC, Mally A, Wool A, Beiman M, Hewitt P. | Vet Pathol. | 2013 | View |
Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics. Burt D, Crowell SJ, Ackley DC, Magee TV, Aubrecht J. | Drug Chem Toxicol. | 2013 | View |
Assessment of cisplatin-induced kidney injury using an integrated rodent platform. Chen Y, Brott D, Luo W, Gangl E, Kamendi H, Barthlow H, Lengel D, Fikes J, Kinter L, Valentin JP, Bialecki R. | Toxicol Appl Pharmacol | 2013 | View |
Early prediction of polymyxin-induced nephrotoxicity with next generation urinary kidney injury biomarkers. Keirstead ND, Wagoner MP, Bentley P, Blais M, Brown C, Cheatham L, Ciaccio P, Dragan Y, Ferguson D, Fikes J, Galvin M, Gupta A, Hale M, Johnson N, Luo W, McGrath F, Pietras M, Price S, Sathe AG, Sasaki JC, Snow D, Walsky RL, Kern G. | Toxicol Sci. | 2013 | View |
Heparanase mediates renal dysfunction during early sepsis in mice. Lygizos MI, Yang Y, Altmann CJ, Okamura K, Hernando AA, Perez MJ, Smith LP, Koyanagi DE, Gandjeva A, Bhargava R, Tuder RM, Faubel S, Schmidt EP. | Physiol Rep. | 2013 | View |
Irreversible renal damage after transient Renin-Angiotensin System stimulation: involvement of an AT1-receptor mediated immune response. Heijnen BF, Nelissen J, van Essen H, Fazzi GE, Cohen Tervaert JW, Peutz-Kootstra CJ, Mullins JJ, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA. | PLoS One | 2013 | View |
Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats. Heijnen BF, Van Essen H, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA. | Hypertens Res. | 2013 | View |
Time course of renal proximal tubule injury, reversal, and related biomarker changes in rats following cisplatin administration. McDuffie JE, Ma JY, Sablad M, Sonee M, Varacallo L, Louden C, Guy A, Vegas J, Liu X, La D, Snook S. | Int J Toxicol. | 2013 | View |
Adora2b Adenosine Receptor Signaling Protects during Acute Kidney Injury via Inhibition of Neutrophil-Dependent TNF-α Release. Grenz A, Kim JH, Bauerle JD, Tak E, Eltzschig HK, Clambey ET. | J Immunol. | 2012 | View |
Comparison of the Diagnostic Accuracy of Di-22:6-Bis(monoacylglycerol)Phosphate and Other Urinary Phospholipids for Drug-Induced Phospholipidosis or Tissue Injury in the Rat. Thompson KL, Haskins K, Rosenzweig BA, Stewart S, Zhang J, Peters D, Knapton A, Rouse R, Mans D, Colatsky T. | Int J Toxicol. | 2012 | View |
Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats. Thompson KL, Zhang J, Stewart S, Rosenzweig BA, Shea K, Mans D, Colatsky T. | Toxicol Lett. | 2012 | View |
Controlled regulation of erythropoietin by primary cultured renal cells for renal failure induced anemia. Gyabaah K, Aboushwareb T, Guimaraes Souza N, Yamaleyeva L, Varner A, Wang HJ, Atala A, Yoo JJ. | J Urol. | 2012 | View |
Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats Starckx S, Batheja A, Verheyen GR, Jonghe SD, Steemans K, Dijck BV, Singer M, Bogdan N, Snoeys J, Vinken P, Sasaki JC, Gompel JV, Guzzie-Peck P, Lampo A, Lammens L. | Toxicol Pathol. | 2012 | View |
Evaluation of novel urinary renal biomarkers: biological variation and reference change values. Pinches MD, Betts CJ, Bickerton SJ, Beattie L, Burdett LD, Thomas HT, Derbyshire NA, Moores M, Price SA. | Toxicol Pathol. | 2012 | View |
Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences. Pinches M, Betts C, Bickerton S, Burdett L, Thomas H, Derbyshire N, Jones HB, Moores M. | Toxicol Pathol. | 2012 | View |
Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media. Rouse RL, Stewart SR, Thompson KL, Zhang J. | Toxicol Pathol. | 2012 | View |
Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependent. Brott DA, Bentley P, Nadella MV, Thurman D, Fikes J, Cheatham L, McGrath F, Luo W, Kinter LB. | Toxicology | 2012 | View |
Underestimation of urinary biomarker-to-creatinine ratio resulting from age-related gain in muscle mass in rats. Tonomura Y, Morikawa Y, Takagi S, Torii M, Matsubara M. | Toxicology | 2012 | View |